Alpha 2.0
Login Register
» Authors » Andrew Hyland

Andrew Hyland

Explore the profile of Andrew Hyland including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 301
Citations 7769
Followers 0
Related Specialties
Public Health
Psychiatry
Oncology
Top 10 Co-Authors
K Michael Cummings
Geoffrey T Fong
Maansi Bansal-Travers
Heather L Kimmel
Kathryn C Edwards
Maciej L Goniewicz
Ron Borland
Richard J OConnor
Nicolette Borek
Cassandra A Stanton
Published In
Nicotine Tob Res
Tob Control
Int J Environ Res Public Health
Addict Behav
Cancer Epidemiol Biomarkers Prev
Affiliations
Soon will be listed here.
Recent Articles
1.
Correction to: Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in waves 1 through 5 (2013-2019) of the population assessment of tobacco and health (PATH) study
Paulin L, Halenar M, Edwards K, Lauten K, Stanton C, Taylor K, et al.
Respir Res . 2025 Mar; 26(1):93. PMID: 40057741
No abstract available.
2.
Functionally important respiratory symptoms and continued cigarette use versus e-cigarette switching: population assessment of tobacco and health study waves 2-6
Sargent J, Lauten K, Edwards K, Tanski S, MacKenzie T, Paulin L, et al.
EClinicalMedicine . 2025 Feb; 79:102951. PMID: 39968205
Background: Substitution of noncombustible tobacco products for cigarettes could improve respiratory symptoms. We hypothesized that complete cigarette-to-e-cigarette switching would improve respiratory symptoms compared to continued smoking. Methods: Longitudinal analysis of...
3.
Corrigendum to "Tobacco Product Use and Functionally Important Respiratory Symptoms Among US Adolescents/Young Adults" [Acad Pediatr. 2022; 22(6):1006-1016]
Tanski S, Halenar M, Edwards K, Emond J, Woloshin S, Brunette M, et al.
Acad Pediatr . 2025 Feb; 25(3):102561. PMID: 39922078
No abstract available.
4.
Corrigendum to "Cardiovascular disease outcomes among established cigar users 40 years and older: Findings from the population assessment of tobacco and health (PATH) study, Waves 1-5 (2013-2019)" [Pre. Med. Rep. 37 (2024) 102569]
Sharma E, Tang Z, Lauten K, Silveira M, Delnevo C, Edwards K, et al.
Prev Med Rep . 2025 Feb; 49:102941. PMID: 39897106
[This corrects the article DOI: 10.1016/j.pmedr.2023.102569.].
5.
Correction: Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Edwards K, Khan A, Sharma E, Wang L, Feng J, Blount B, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):206. PMID: 39780623
No abstract available.
6.
Correction: Urinary Cotinine and Cotinine + Trans-3'-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013-2014)
Edwards K, Naz T, Stanton C, Goniewicz M, Hatsukami D, Smith D, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):208. PMID: 39780622
No abstract available.
7.
Correction: Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014)
Cheng Y, Reyes-Guzman C, Christensen C, Rostron B, Edwards K, Wang L, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):209. PMID: 39780620
No abstract available.
8.
Correction: Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users- Results from Wave 1 PATH Study
Christensen C, Chang J, Rostron B, Hammad H, van Bemmel D, Del Valle-Pinero A, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):207. PMID: 39780619
No abstract available.
9.
Differences in smoking cessation behaviors and vaping status among adult daily smokers with and without depression, anxiety, and alcohol use: Findings from the 2018 and 2020 International Tobacco Control Four Country Smoking and Vaping (ITC 4CV)...
Yimsaard P, Gravely S, Meng G, Fong G, Cummings K, Hyland A, et al.
Int J Ment Health Addict . 2024 Dec; 22(6):3433-3450. PMID: 39735821
This study examined differences in quit attempts, 1-month quit success, and vaping status at follow-up among a cohort of 3709 daily smokers with and without depression, anxiety, and regular alcohol...
10.
Prevalence and correlates of negative side effects from vaping nicotine: Findings from the 2020 ITC four country smoking and vaping survey
Yong H, Hughes L, Borland R, Gravely S, Cummings K, Brose L, et al.
Drug Alcohol Depend . 2024 Nov; 266:112503. PMID: 39608290
Introduction: This study examined prevalence and correlates of self-reported negative side effects from nicotine vaping product (NVP) use among people who currently or recently vape. Methods: This cross-sectional study analysed...